share_log

Cardio Diagnostics | D: Filing D

SEC announcement ·  Feb 6 12:30
Summary by Moomoo AI
Cardio Diagnostics Holdings, Inc. has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an equity offering with the first sale dated 02/02/2024. The biotechnology company, incorporated in Delaware within the last five years, is headquartered in Chicago, Illinois. Key executives and directors, including Meeshanthini Dogan, Warren Hosseinionn, Oded Levy, Robert Philibert, Elisa Luqman, Stanley Lau, Paul Burton, and James Intrater, are listed in the filing. Cardio Diagnostics Holdings has opted not to disclose its revenue range or aggregate net asset value. The offering, which does not exceed one year, involves common stock and warrants to purchase common stock, with a minimum investment of $50,000 from outside investors. The total offering and amount...Show More
Cardio Diagnostics Holdings, Inc. has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an equity offering with the first sale dated 02/02/2024. The biotechnology company, incorporated in Delaware within the last five years, is headquartered in Chicago, Illinois. Key executives and directors, including Meeshanthini Dogan, Warren Hosseinionn, Oded Levy, Robert Philibert, Elisa Luqman, Stanley Lau, Paul Burton, and James Intrater, are listed in the filing. Cardio Diagnostics Holdings has opted not to disclose its revenue range or aggregate net asset value. The offering, which does not exceed one year, involves common stock and warrants to purchase common stock, with a minimum investment of $50,000 from outside investors. The total offering and amount sold are both listed as $1,000,000 USD, with no remaining to be sold. Sales commissions are estimated at $100,000 USD, with no finder's fees. The offering is not made in connection with a business combination transaction, and the proceeds are not intended for payments to the named executives, directors, or promoters. The company has claimed an exemption under Rule 506(b) and has completed the offering with seven investors.

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more